Combat Drugs’ wholly owned subsidiary company---ICP Solutions has formalized and signed a two year contract for export of services with a leading firm handling and operating multiple Client base in the United States of America.
The Gross Revenue that will be generated from this contact, as agreed upon, will be $1.44 Million equivalent to approximately around Rs 10.10 crore. Further, the company is also in the process of negotiations with various other companies and is conducting trials for the services for few corporates.
Combat Drugs manufactures and markets pharmaceutical formulations in India. The company offers its products in various forms, such as tablets, capsules, liquid orals, and ointments.
